MMP9 and cancer: Our group and others have shown that the amount of matrix metalloproteinase (MMP)-9 in the blood, a biomarker relevant for the prognosis of stroke [17] and cancer [18], can be critically affected by HMWH [19,20,21,22], an effect potentially impeding adequate treatment decisions.